AwardTape · Defense awards · Emergent Biosolutions · Emergent Product Development Gaithersburg Inc
Emergent Product Development Gaithersburg Inc: -$1.1M in DoD and DHS awards (this registration)
This registration, Emergent Product Development Gaithersburg Inc, holds 1 DoD and DHS prime award with -$1.1M obligated Jul 17, 2024 to Jul 17, 2024. Largest category: Health R&D at -$1.1M; largest buyer: Department of the Army at -$1.1M.
| Obligated FY2024+ | -$1.1M |
|---|---|
| Awards | 1 |
| FY2024 | -$1.1M |
| FY2025 | $0 |
| FY2026 to date | $0 |
| Lifetime obligated on these awards | $5.7M |
| Parent company | Emergent Biosolutions: $62.2M in DoD and DHS awards since FY2024 across 3 registrations |
| First and latest action | Jul 17, 2024 · Jul 17, 2024 |
| # | Category | Obligated FY2024+ | Awards | Share |
|---|---|---|---|---|
| 1 | Health R&D | -$1.1M | 1 awards | 100% |
| # | Agency | Obligated FY2024+ | Awards | Share |
|---|---|---|---|---|
| 1 | Department of the Army | -$1.1M | 1 awards | 100% |
| Award | Obligated FY2024+ | What | Agency | Category | Latest action |
|---|---|---|---|---|---|
| W81XWH19C0193 definitive contract | -$1.1M | Creation of an fda approved analgesic ketamine drug with auto injector delivery system. | Army | Health R&D | Jul 17, 2024 DoD 90d |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Data as of Oct 9, 2026.
Terminal: filters, alerts and CSV export for this company's awards.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial